The field of HCV therapeutics continues to evolve rapidly and, since the World Health Organization (WHO) issued its first Guidelines for the screening, care and treatment of persons with hepatitis C infection in 2014, several new medicines have been approved by at least one stringent regulatory authority...
Objetivo: brindar una guía de práctica clínica basada en la evidencia más reciente para el diagnóstico y tratamiento de la infección por Helicobacter pylori teniendo en cuenta la efectividad y seguridad de las intervenciones dirigidas a pacientes, personal asistencial, administrativo y entes gubern...
The overall objective of the guidelines is to provide public health approach guidance on evidencebased practices for testing, treating and managing LTBI in individuals with the highest risk of progression to active disease. The guidelines are expected to provide the basis and rationale for the developmen...
Malaria case management, which consists of prompt diagnosis and effective treatment, remains a vital component of malaria control and elimination strategies. This third edition of the WHO Guidelines for the treatment of malaria contains updated recommendations based on new evidence as well as a recommend...
Raghu, Ganesh;
Rochwerg, Bram;
Zhang, Yuan;
Cuello Garcia, Carlos A;
Azuma, Arata;
Behr, Juergen;
Brozek, Jan L;
Collard, Harold R;
Cunningham, William;
Homma, Sakae;
Johkoh, Takeshi;
Martinez, Fernando J;
Myers, Jeffrey;
Protzko, Shandra L;
Richeldi, Luca;
Rind, David;
Selman, Moisés;
Theodore, Arthur;
Wells, Athol U;
Hoogsteden, Henk;
Schünemann, Holger J.
Background: This document updates the American Thoracic Society/European Respiratory Society/Japanese Respiratory Society/Latin American Thoracic Association guideline on idiopathic pulmonary fibrosis treatment. Methods: Systematic reviews and, when appropriate, meta-analyses were performed to summarize ...
Hépatite C,
Antiviraux/usage thérapeutique,
Hépatite C/diagnostic,
Transplantation hépatique,
Contre-indications,
Surveillance des médicaments,
Association de médicaments,
Interférons/usage thérapeutique,
Maladie aigüe,
Hépatite C/étiologie,
Hépatite C/thérapie,
Hépatite C chronique/diagnostic,
Hépatite C chronique/étiologie,
Hépatite C chronique/thérapie
The aim of this guidance is to provide the interim principles that should guide the use of delamanid in conjunction with WHO-recommended MDR-TB treatment. It also specifies the essential treatment and management conditions for use of this drug, in particular the patient's eligibility criteria and safety ...
This Guideline outlines the purpose and the target audience of the second edition of Guidance for national tuberculosis programmes on the management of tuberculosis in children. It discusses the difference between TB in children and adolescents and TB in adults and provides an estimate of the burden of c...
DESCRIPTION: The American College of Physicians (ACP) developed this guideline to present the evidence and provide clinical recommendations on the screening, monitoring, and treatment of adults with stage 1 to 3 chronic kidney disease. METHODS: This guideline is based on a systematic evidence review eval...
Insuffisance rénale chronique/diagnostic,
Insuffisance rénale chronique/traitement médicamenteux,
Évolution de la maladie,
Triage,
Antagonistes des récepteurs aux angiotensines/usage thérapeutique,
Inhibiteurs de l'enzyme de conversion de l'angiotensine/usage thérapeutique,
Antihypertenseurs/usage thérapeutique,
Inhibiteurs de l'hydroxyméthylglutaryl-CoA réductase/usage thérapeutique,
Hypolipémiants/usage thérapeutique,
Gemfibrozil/usage thérapeutique,
Maladies asymptomatiques,
Association de médicaments,
Approche GRADE
Increasing access to antiretroviral therapy (ART) has transformed the prognosis of HIVinfected patients in resource-limited settings (RLS). However, treatment coverage remains relatively low, and HIV diagnosis occurs at a late stage. As a result, many patients continue to die of HIV-related opportunistic...
Cryptococcose/diagnostic,
Flucytosine/administration et posologie,
Antifongiques/administration et posologie,
Infections opportunistes liées au SIDA/microbiologie,
Fluconazole/administration et posologie,
Amphotéricine B/administration et posologie,
Cryptococcose,
Cryptococcose/traitement médicamenteux,
Cryptococcose/prévention et contrôle,
Méningite cryptococcique/traitement médicamenteux,
Association de médicaments
